Lauri Aaltonen#


Lauri Aaltonen
Membership Number:6906
Membership type:ORDINARY
Section:CLINICAL & VETERINARY SCIENCE
Elected:2024
Main Country of Residence:FINLAND
Homepage(s):https://www.helsinki.fi/en/researchgroups/tumor-genomics/research
ORCID:0000-0001-6839-4286





Present and Previous Positions
  • 2018 - 2025 Director, Academy of Finland’s Centre of Excellence in Tumor Genetics Research
  • 2019 Director, Applied Tumor Genomics Research Program, University of Helsinki
  • 2019 - 2026 Vice Scientific Director, iCAN national flagship Project
  • 2020 - 2024 Visiting PI, Karolinska Institute, Cancer Genetics, Stockholm, Sweden
  • 2018 Member of the Board, FICAN South
  • 2016 Vice Board Member, Helsinki Institute of Life Science (HILIFE)
  • 2007 Professor of Tumor Genomics, University of Helsinki
  • 2002 - 2007, 2008 - 2017, 2019 Academy Professor
  • 2010 Member, European Academy of Cancer Sciences (invitation)
  • 2002 Member, Finnish Academy of Science and Letters (invitation)
  • 2000 Member, European Molecular Biology Organization EMBO (invitation)
  • 1996 Docent (Medical molecular genetics), University of Helsinki
  • 2012 - 2020 Scientific Advisory Board member, Finnish Cancer Institute
  • 2012 - 2017 Director, Academy of Finland’s Center of Excellence in Cancer Genetics Research
  • 2015 - 2020 Visiting Professor, Cancer Genetics, Karolinska Institute, Stockholm, Sweden
  • 2016 - 2021 ERC Advanced Grant PI, “Towards prevention, early diagnosis, and noninvasive treatment of uterine leiomyomas through molecular classification” 2016-2021
  • 2011 - 2016 ERC Advanced Grant PI, “Next generation genetics of cancer predisposition”

Fields of Scholarship
  • Colorectal cancer
  • Tumor
  • Cancer
  • Uterine leiomyoma
  • Genetics & heredity

Honours and Awards
  • 2016 - 2021 ERC Advanced Grant PI, “Towards prevention, early diagnosis, and noninvasive treatment of uterine leiomyomas through molecular classification” 2016-2021
  • 2011 - 2016 ERC Advanced Grant PI, “Next generation genetics of cancer predisposition"
  • 2006 Matti Äyräpää Prize (main national medical research prize)
  • 2005 University of Helsinki's Occupational safety and health award (Award for the whole group, for excellence in Occupational Safety and Health)
  • 2005 Nominee for Descartes Prize (project CANCERGENES, with Ian Tomlinson)
  • 2003 Medix Prize for Biosciences 2003, for publication number 82 (National award for best biomedical publication of the year, to all coauthors)
  • 2000 Anders Jahre Medical Prize for young scientists (Nordic countries award, under 40)
  • 1999 Sigrid Juselius Foundation, Young Medical Researcher Award (national award, under 40)
  • 1999 Institut des Sciences de la Santé Europe & Médecine Junior Prize (EU award in medicine, under 40)
  • 1998 European Association for Cancer Research, Young Cancer Researcher Award (European Award, under 35)
  • 1995 Pharmacia Biotech & Science Prize for Young Scientists, European Winner (Global Award, thesis prize with no age limit)

Imprint Privacy policy « This page (revision-7) was last changed on Monday, 13. May 2024, 13:46 by Kaiser Dana
  • operated by